Satori Pharmaceuticals
About:
Satori Pharmaceuticals develops disease-modifying therapies for alzheimer's, parkinson's and other neurodegenerative disorders.
Website: http://www.satoripharma.com
Twitter/X: meetornext
Top Investors: New Enterprise Associates, PureTech Health, InterWest Partners, Prospect Venture Partners
Description:
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.
Total Funding Amount:
$47.3M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2005-01-01
Founders:
Mark Findeis
Number of Employees:
11-50
Last Funding Date:
2012-02-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai